Minnesota Oncology Physicians recognized as “Top Doctors” in 2023 by Minnesota Monthly

Minnesota Oncology is proud to announce the following physicians who were named to the Top Doctors 2023 list.

Congratulations to all our Top Doctors at Minnesota Oncology who are an amazing example of the great care we strive to provide to patients every day!

Breast Surgery

Gynecologic Oncology

Hematology

Oncology

Palliative Care

Plastic Surgery

Radiation Oncology

Thoracic Surgery

The 2023 Top Doctors are all listed in the September/October issue of the magazine which is available on newsstands now. The full list is also available on Minnesota Monthly’s website.

Congratulations to ALL the excellent physicians across the Twin Cities. We are honored to be part of the Twin Cities' community of care!

 

What you need to know about Minnesota Monthly’s Top Doctor Survey

Who pick’s the doctors?
In March, Professional Research Services (PRS) contacted more than 10,000 licensed doctors in the 11-county metro area, as well as Olmstead County, based on a list provided by the Minnesota Board of Medical Practice. They were asked to log on to a secure website and name up to three doctors (other than themselves) in each specialty category. Physicians who received the highest number of votes are recognized on the list.

How were the specialties selected?
The American Board of Medical Specialties recognizes 24 member boards that grant certification in specialized areas of medical practice.

 

Share

Categories

Tags

Recent Posts

#
November 21, 2024

If you don’t smoke, you’ve eliminated one of the biggest risk factors for developing lung cancer. But in the United States, about 10% to 20% of lung cancer diagnoses happen in people who have never smoked or have smoked fewer than 100 cigarettes in their lifetime.

#
November 19, 2024

Minnesota Oncology Warns Against Vaping During Lung Cancer Awareness Month

#
November 14, 2024

Biomarkers are proteins, hormones, or pieces of DNA that can be released by cancer cells or by your body in response to cancer.